Literature DB >> 30518722

Ectopic fat, insulin resistance and metabolic disease in non-obese Asians: investigating metabolic gradation.

Yoshifumi Tamura1,2,3.   

Abstract

Although metabolic abnormalities commonly occur in non-obese Asians, their pathogenesis is not fully understood. Proton magnetic resonance spectroscopy has been used to analyze intracellular lipids in humans, and results suggest that ectopic fat accumulation in muscle and liver may induce insulin resistance in each tissue independently of obesity. Thus, measurement of ectopic fat currently plays an important role in the study of insulin resistance in non-obese Asians. In addition, studies using 2-step hyperinsulinemic euglycemic clamp with a glucose tracer may clarify how tissue-specific insulin resistance in muscle, liver, and adipose tissue contributes to the development of metabolic disease in non-obese Japanese. Although numerous studies have elucidated the pathophysiology of insulin resistance in obese subjects, research on "metabolic gradation," defined as the gradual transition from an insulin-sensitive to an insulin-resistant state, is less common, especially in terms of early metabolic changes. This review addresses a simple question: when and how is insulin resistance induced in non-obese East Asians? Several studies revealed that impaired insulin clearance and hyperinsulinemia not only compensated for insulin resistance, but also secondarily facilitated insulin resistance and weight gain. In this regard, we recently found that impaired insulin clearance and hyperinsulinemia could occur in apparently healthy subjects without significant insulin resistance, suggesting that this change may be an initial trigger that drives subsequent insulin resistance and weight gain. Further research is required to clarify the pathogenesis of metabolic gradation in non-obese Asians.

Entities:  

Keywords:  Insulin resistance; Intrahepatic lipid; Intramyocellular lipid; Non-obese East Asian; Physical activity

Mesh:

Substances:

Year:  2018        PMID: 30518722     DOI: 10.1507/endocrj.EJ18-0435

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

1.  Metabolism Score for Visceral Fat (METS-VF): A New Predictive Surrogate for CKD Risk.

Authors:  Ling Feng; Tong Chen; Xuan Wang; Chongxiang Xiong; Jianhui Chen; Shiquan Wu; Jing Ning; Hequn Zou
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-29       Impact factor: 3.249

2.  PI3K/Akt pathway expression in children with different obesity degrees and its relationship with glucolipid metabolism and insulin resistance.

Authors:  Xiaoyan Su; Deming Gu; Li Xu; Zhenming Liang; Xuan Luo; Pu Yang; Jing Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Clustering of Lifestyle Factors and Its Association with Low Back Pain: A Cross-Sectional Study of Over 400,000 Japanese Adults.

Authors:  Takahiko Yoshimoto; Hirotaka Ochiai; Takako Shirasawa; Satsue Nagahama; Akihito Uehara; Jun Muramatsu; Akatsuki Kokaze
Journal:  J Pain Res       Date:  2020-06-12       Impact factor: 3.133

4.  Triglyceride Induced Metabolic Inflammation: Potential Connection of Insulin Resistance and Recurrent Pregnancy Loss.

Authors:  Yongjie Liu; Mengyang Du; Yuexin Gan; Shihua Bao; Liping Feng; Jun Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-15       Impact factor: 5.555

5.  The association of pericardial fat and peri-aortic fat with severity of nonalcoholic fatty liver disease.

Authors:  Chun-Wei Lee; Chun-Ho Yun; Wen-Hung Huang; Ta-Chuan Hung; Cheng-Ting Tsai; Jen-Yuan Kuo; Cheng-Huang Su; Han-En Cheng; Chung-Lieh Hung; Charles Jia-Yin Hou
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

6.  Circulating CRP Levels Are Associated with Epicardial and Visceral Fat Depots in Women with Metabolic Syndrome Criteria.

Authors:  Federico Carbone; Maria Stefania Lattanzio; Silvia Minetti; Anna Maria Ansaldo; Daniele Ferrara; Emilio Molina-Molina; Anna Belfiore; Edoardo Elia; Stefania Pugliese; Vincenzo Ostilio Palmieri; Fabrizio Montecucco; Piero Portincasa
Journal:  Int J Mol Sci       Date:  2019-11-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.